Gender-dependent differences in uridine 5'-diphospho-glucuronosyltransferase have implications in metabolism and clearance of xenobiotics

Bibliography

• Kamada N, Yamada K, Odomi M, et al. Sex differences in pharmacokinetics of cilostazol in rats. Xenobiotica 2011;41(10):903-13
   PubMed Web of Science ®Google Scholar
• Coldham NG, Zhang AQ, Key P, Sauer MJ. Absolute bioavailability of [14C] genistein in the rat; plasma pharmacokinetics of parent compound, genistein glucuronide and total radioactivity. Eur J Drug Metab Pharmacokinet 2002;27(4):249-58
   PubMed Web of Science ®Google Scholar
• Kulkarni KH, Yang Z, Niu T, Hu M. Effects of estrogen and estrus cycle on pharmacokinetics, absorption, and disposition of genistein in female Sprague-Dawley rats. J Agric Food Chem 2012;60(32):7949-56
   PubMed Web of Science ®Google Scholar
• Liu W, Tang L, Ye L, et al. Species and gender differences affect the metabolism of emodin via glucuronidation. AAPS J 2010;12(3):424-36
   PubMed Web of Science ®Google Scholar
• Buckley DB, Klaassen CD. Tissue- and gender-specific mRNA expression of UDP-glucuronosyltransferases (UGTs) in mice. Drug Metab Dispos 2007;35(1):121-7
   PubMed Web of Science ®Google Scholar
• Buckley DB, Klaassen CD. Mechanism of gender-divergent UDP-glucuronosyltransferase mRNA expression in mouse liver and kidney. Drug Metab Dispos 2009;37(4):834-40
   PubMed Web of Science ®Google Scholar
• Shelby MK, Cherrington NJ, Vansell NR, Klaassen CD. Tissue mRNA expression of the rat UDP-glucuronosyltransferase gene family. Drug Metab Dispos 2003;31(3):326-33
   PubMed Web of Science ®Google Scholar
• Murray HE, Simonian SX, Herbison AE, Gillies GE. Correlation of hypothalamic somatostatin mRNA expression and peptide content with secretion: sexual dimorphism and differential regulation by gonadal factors. J Neuroendocrinol 1999;11(1):27-33
   PubMed Web of Science ®Google Scholar
• Waxman DJ, Holloway MG. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 2009;76(2):215-28
   PubMed Web of Science ®Google Scholar
• Shimokawa N, Kato Y, Imai K, Wakabayashi K. Changes in content of prolactin mRNA during the rat estrous cycle. Exp Clin Endocrinol 1990;96(1):8-14
   PubMedGoogle Scholar
• Lee SY, Oh SJ, Yun KU, et al. Expression of hepatic and ovarian cytochrome P450 during estrous cycle in rats. Arch Toxicol 2012;86(1):75-85
   PubMed Web of Science ®Google Scholar
• Coldham NG, Sauer MJ. Pharmacokinetics of [(14)C]Genistein in the rat: gender-related differences, potential mechanisms of biological action, and implications for human health. Toxicol Appl Pharmacol 2000;164(2):206-15
   PubMed Web of Science ®Google Scholar
• Jiang W, Xu B, Wu B, et al. UDP-glucuronosyltransferase (UGT) 1A9-overexpressing HeLa cells is an appropriate tool to delineate the kinetic interplay between breast cancer resistance protein (BRCP) and UGT and to rapidly identify the glucuronide substrates of BCRP. Drug Metab Dispos 2012;40(2):336-45
   PubMed Web of Science ®Google Scholar
• Kadakol A, Ghosh SS, Sappal BS, et al. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat 2000;16(4):297-306
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhu W, Gao S, et al. Breast cancer resistance protein (ABCG2) determines distribution of genistein Phase II metabolites: reevaluation of the roles of ABCG2 in the disposition of genistein. Drug Metab Dispos 2012;40(10):1883-93
   PubMed Web of Science ®Google Scholar
• Guengerich FP. Uncommon P450-catalyzed reactions. Curr Drug Metab 2001;2(2):93-115
   PubMed Web of Science ®Google Scholar
• Faed EM. Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metab Rev 1984;15(5-6):1213-49
   PubMed Web of Science ®Google Scholar
• King CD, Rios GR, Green MD, Tephly TR. UDP-glucuronosyltransferases. Curr Drug Metab 2000;1(2):143-61
   PubMed Web of Science ®Google Scholar
• Sorich MJ, Miners JO, McKinnon RA, Smith PA. Multiple pharmacophores for the investigation of human UDP-glucuronosyltransferase isoform substrate selectivity. Mol Pharmacol 2004;65(2):301-8
   PubMed Web of Science ®Google Scholar
• Liu W, Zheng Z, Liu X, et al. Sensitive and robust UPLC-MS/MS method to determine the gender-dependent pharmacokinetics in rats of emodin and its glucuronide. J Pharm Biomed Anal 2011;54(5):1157-62
   PubMed Web of Science ®Google Scholar
• Hamaoka N, Oda Y, Hase I, Asada A. Cytochrome P4502B6 and 2C9 do not metabolize midazolam: kinetic analysis and inhibition study with monoclonal antibodies. Br J Anaesth 2001;86(4):540-4
   PubMed Web of Science ®Google Scholar
• Wang SW, Kulkarni KH, Tang L, et al. Disposition of flavonoids via enteric recycling: UDP-glucuronosyltransferase (UGT) 1As deficiency in Gunn rats is compensated by increases in UGT2Bs activities. J Pharmacol Exp Ther 2009;329(3):1023-31
   PubMed Web of Science ®Google Scholar
• Meng S, Wu B, Singh R, et al. SULT1A3-mediated regiospecific 7-O-sulfation of flavonoids in Caco-2 cells can be explained by the relevant molecular docking studies. Mol Pharm 2012;9(4):862-73
   PubMed Web of Science ®Google Scholar
• Wu B, Basu S, Meng S, et al. Regioselective sulfation and glucuronidation of phenolics: insights into the structural basis. Curr Drug Metab 2011;12(9):900-16
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhu W, Gao S, et al. Simultaneous determination of genistein and its four Phase II metabolites in blood by a sensitive and robust UPLC-MS/MS method: application to an oral bioavailability study of genistein in mice. J Pharm Biomed Anal 2010;53(1):81-9
   PubMed Web of Science ®Google Scholar
• Luquita MG, Catania VA, Pozzi EJ, et al. Molecular basis of perinatal changes in UDP-glucuronosyltransferase activity in maternal rat liver. J Pharmacol Exp Ther 2001;298(1):49-56
   PubMed Web of Science ®Google Scholar
• Luquita MG, Catania VA, Sanchez Pozzi EJ, et al. Induction of phase II biotransformation reactions in rat jejunum during lactation. Possible involvement of prolactin. Biochim Biophys Acta 1999;1472(1-2):82-92
   PubMed Web of Science ®Google Scholar
• Luquita MG, Catania VA, Sanchez-Pozzi EJ, Mottino AD. Ovine prolactin increases hepatic UDP-glucuronosyltransferase activity in ovariectomized rats. J Pharmacol Exp Ther 1996;278(2):921-5
   PubMed Web of Science ®Google Scholar
• Mercke Odeberg J, Andrade J, Holmberg K, et al. UGT1A polymorphisms in a Swedish cohort and a human diversity panel, and the relation to bilirubin plasma levels in males and females. Eur J Clin Pharmacol 2006;62(10):829-37
   PubMed Web of Science ®Google Scholar
• Fu ZD, Csanaky IL, Klaassen CD. Effects of aging on mRNA profiles for drug-metabolizing enzymes and transporters in livers of male and female mice. Drug Metab Dispos 2012;40(6):1216-25
   PubMed Web of Science ®Google Scholar
• Chen LJ, Wegerski CJ, Kramer DJ, et al. Disposition and metabolism of cumene in F344 rats and B6C3F1 mice. Drug Metab Dispos 2011;39(3):498-509
   PubMed Web of Science ®Google Scholar
• Baker L, Ratka A. Sex-specific differences in levels of morphine, morphine-3-glucuronide, and morphine antinociception in rats. Pain 2002;95(1-2):65-74
   PubMed Web of Science ®Google Scholar
• Court MH, Krishnaswamy S, Hao Q, et al. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism. Drug Metab Dispos 2003;31(9):1125-33
   PubMed Web of Science ®Google Scholar
• Ishii Y, Takami A, Tsuruda K, et al. Induction of two UDP-glucuronosyltransferase isoforms sensitive to phenobarbital that are involved in morphine glucuronidation: production of isoform-selective antipeptide antibodies toward UGT1.1r and UGT2B1. Drug Metab Dispos 1997;25(2):163-7
   PubMed Web of Science ®Google Scholar
• Alnouti YM, Shelby MK, Chen C, Klaassen CD. Influence of phenobarbital on morphine metabolism and disposition: LC-MS/MS determination of morphine (M) and morphine-3-glucuronide (M3G) in Wistar-Kyoto rat serum, bile, and urine. Curr Drug Metab 2007;8(1):79-89
   PubMed Web of Science ®Google Scholar
• Wang JJ, Lu H, Chan KK. Stereoselective pharmacokinetics of ifosfamide in male and female rats. AAPS PharmSci 2000;2(2):E17
   PubMedGoogle Scholar
• Court MH. Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system. Drug Metab Rev 2010;42(1):209-24
   PubMed Web of Science ®Google Scholar
• Court MH. Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases. Methods Enzymol 2005;400:104-16
   PubMed Web of Science ®Google Scholar
• Court MH, Hao Q, Krishnaswamy S, et al. UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver. J Pharmacol Exp Ther 2004;310(2):656-65
   PubMed Web of Science ®Google Scholar
• Kosoglou T, Statkevich P, Johnson-Levonas AO, et al. Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet 2005;44(5):467-94
   PubMed Web of Science ®Google Scholar
• Miners JO, Attwood J, Birkett DJ. Influence of sex and oral contraceptive steroids on paracetamol metabolism. Br J Clin Pharmacol 1983;16(5):503-9
   PubMed Web of Science ®Google Scholar
• Available from: http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020815a_bphrev-2.pdf
   Google Scholar
• Chen J, Lin H, Hu M. Metabolism of flavonoids via enteric recycling: role of intestinal disposition. J Pharmacol Exp Ther 2003;304(3):1228-35
   PubMed Web of Science ®Google Scholar
• Jia X, Chen J, Lin H, Hu M. Disposition of flavonoids via enteric recycling: enzyme-transporter coupling affects metabolism of biochanin A and formononetin and excretion of their phase II conjugates. J Pharmacol Exp Ther 2004;310(3):1103-13
   PubMed Web of Science ®Google Scholar
• Lu H, Klaassen C. Gender differences in mRNA expression of ATP-binding cassette efflux and bile acid transporters in kidney, liver, and intestine of 5/6 nephrectomized rats. Drug Metab Dispos 2008;36(1):16-23
   PubMed Web of Science ®Google Scholar
• Rost D, Kopplow K, Gehrke S, et al. Gender-specific expression of liver organic anion transporters in rat. Eur J Clin Invest 2005;35(10):635-43
   PubMed Web of Science ®Google Scholar
• MacLean C, Moenning U, Reichel A, Fricker G. Closing the gaps: a full scan of the intestinal expression of p-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in male and female rats. Drug Metab Dispos 2008;36(7):1249-54
   PubMed Web of Science ®Google Scholar
• Lee JK, Abe K, Bridges AS, et al. Sex-dependent disposition of acetaminophen sulfate and glucuronide in the in situ perfused mouse liver. Drug Metab Dispos 2009;37(9):1916-21
   PubMed Web of Science ®Google Scholar
• Lifschitz A, Ballent M, Virkel G, et al. Sex-related differences in the gastrointestinal disposition of ivermectin in the rat: P-glycoprotein involvement and itraconazole modulation. J Pharm Pharmacol 2006;58(8):1055-62
   PubMed Web of Science ®Google Scholar
• Trottier J, Perreault M, Rudkowska I, et al. Profiling serum bile acid glucuronides in humans: gender divergences, genetic determinants and response to fenofibrate. Clin Pharmacol Ther 2013; [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Wittwer E, Kern SE. Role of morphine's metabolites in analgesia: concepts and controversies. AAPS J 2006;8(2):E348-52
   PubMed Web of Science ®Google Scholar